Fernández-Pajarín G, Sesar A, Relova J L, Ares B, Jiménez-Martín I, Blanco-Arias P, Gelabert-González M, Castro A
Department of Neurology, Hospital Clínico Universitario de Santiago, Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
Department of Clinical Neurophysiology, Hospital Clínico Universitario de Santiago, Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
Acta Neurochir (Wien). 2016 Oct;158(10):2023-8. doi: 10.1007/s00701-016-2904-3. Epub 2016 Aug 17.
Myoclonus-dystonia syndrome (MDS) is an autosomal dominant movement disorder caused by mutations in the SGCE gene. MDS is characterized by mild dystonia and myoclonic jerks, and a constellation of psychiatric manifestations. Deep brain stimulation (DBS) of bilateral internal globus pallidus (GPi) has recently been introduced as a new and beneficial technique to improve motor symptoms in MDS.
We report three proven genetically MDS cases with successful response to DBS, and their clinical evolution over years.
DBS improves significantly the Unified Myoclonus Rating Scale and Burke-Fahn-Marsden Dystonia Rating Scale in all three patients. This improvement is sustained over the years and no major adverse events were recorded. DBS stimulation parameters employed are justified and compared with cases reported throughout the literature.
DBS of bilateral GPi is an effective and safe therapy to be considered in MDS refractory cases. Careful neuropsychological evaluation is essential inside the presurgery planning. Correct location of the DBS electrodes and individualized selection of stimulation parameters in each case are the main determinants of the best clinical response.
肌阵挛性肌张力障碍综合征(MDS)是一种由SGCE基因突变引起的常染色体显性运动障碍。MDS的特征是轻度肌张力障碍和肌阵挛性抽搐,以及一系列精神症状。双侧苍白球内侧部(GPi)的深部脑刺激(DBS)最近被引入作为一种改善MDS运动症状的新的有益技术。
我们报告了3例经基因证实的MDS病例,对DBS治疗反应良好,并报告了他们多年来的临床进展。
DBS显著改善了所有3例患者的统一肌阵挛评分量表和伯克-法恩-马尔登肌张力障碍评分量表。这种改善多年来一直持续,且未记录到重大不良事件。所采用的DBS刺激参数合理,并与文献报道的病例进行了比较。
双侧GPi的DBS是MDS难治性病例中一种有效且安全的治疗方法。术前规划中仔细的神经心理学评估至关重要。DBS电极的正确定位和每个病例中刺激参数的个体化选择是获得最佳临床反应的主要决定因素。